Original paper

P1.04-41 Immunotherapy Concomitant to Radiotherapy: A Multicentric Retrospective Study on 179 Patients with Advanced Non-Small Cell Lung Cancer

Volume: 14, Issue: 10, Pages: S456 - S456
Published: Oct 1, 2019
Abstract
Immunotherapy (IT) has enhanced the treatment armamentarium for aNSCLC. Radiobiological studies and initial clinical reports suggest a potential synergistic effect of radiotherapy (RT) and IT. Aim of the study is to investigate the safety of cytoreductive RT (palliative or ablative) delivered in association with Nivolumab (NIVO), Pembrolizumab (PEM) or Atezolizumab (ATE) in aNSCLC setting. We analyzed 179 consecutive pts affected by aNSCLC...
Paper Details
Title
P1.04-41 Immunotherapy Concomitant to Radiotherapy: A Multicentric Retrospective Study on 179 Patients with Advanced Non-Small Cell Lung Cancer
Published Date
Oct 1, 2019
Volume
14
Issue
10
Pages
S456 - S456
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.